BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17379003)

  • 1. Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis.
    Nakayama H; Otabe S; Ueno T; Hirota N; Yuan X; Fukutani T; Hashinaga T; Wada N; Yamada K
    Metabolism; 2007 Apr; 56(4):470-5. PubMed ID: 17379003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adiponectin transgenic expression in liver of nonalcoholic steatohepatitis model mice.
    Nakayama H; Otabe S; Yuan X; Ueno T; Hirota N; Fukutani T; Wada N; Hashinaga T; Yamada K
    Metabolism; 2009 Jul; 58(7):901-8. PubMed ID: 19394977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue.
    Ueno T; Torimura T; Nakamura T; Sivakumar R; Nakayama H; Otabe S; Yuan X; Yamada K; Hashimoto O; Inoue K; Koga H; Sata M
    Int J Mol Med; 2009 Jul; 24(1):17-22. PubMed ID: 19513529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
    Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
    Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model.
    Kakino S; Ohki T; Nakayama H; Yuan X; Otabe S; Hashinaga T; Wada N; Kurita Y; Tanaka K; Hara K; Soejima E; Tajiri Y; Yamada K
    Horm Metab Res; 2018 Jan; 50(1):80-87. PubMed ID: 28922680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M; Masaki T; Seike M; Yoshimatsu H
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance].
    Tamura Y; Kawamori R
    Nihon Rinsho; 2006 Jun; 64(6):1071-4. PubMed ID: 16768111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo promoter analysis on refeeding response of hepatic sterol regulatory element-binding protein-1c expression.
    Takeuchi Y; Yahagi N; Nakagawa Y; Matsuzaka T; Shimizu R; Sekiya M; Iizuka Y; Ohashi K; Gotoda T; Yamamoto M; Nagai R; Kadowaki T; Yamada N; Osuga J; Shimano H
    Biochem Biophys Res Commun; 2007 Nov; 363(2):329-35. PubMed ID: 17880923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S; Ahtialansaari T; Huotari A; Kiehne K; Fölsch UR; Wolffram S; Jänne J; Alhonen L; Herzig KH
    Acta Physiol (Oxf); 2008 Sep; 194(1):57-65. PubMed ID: 18394026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis.
    Ueno T; Nakamura A; Nakayama H; Otabe S; Yuan X; Fukutani T; Iwamoto H; Nakamura T; Koga H; Torimura T; Sata M; Yamada K
    Exp Ther Med; 2011 Nov; 2(6):1035-1040. PubMed ID: 22977616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity.
    Matsuzawa-Nagata N; Takamura T; Ando H; Nakamura S; Kurita S; Misu H; Ota T; Yokoyama M; Honda M; Miyamoto K; Kaneko S
    Metabolism; 2008 Aug; 57(8):1071-7. PubMed ID: 18640384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A; Papouchado BG; Li Z; Lopez R; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstrain differences in susceptibility to non-alcoholic steatohepatitis.
    Yamazaki Y; Kakizaki S; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
    J Gastroenterol Hepatol; 2008 Feb; 23(2):276-82. PubMed ID: 17868334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.